Amyloidosis Center News
Phase 3 CARDIO-TTRansform Trial Results: New Insights into Eplontersen for ATTR Cardiomyopathy
The Phase 3 CARDIO-TTRansform trial of eplontersen in ATTR cardiomyopathy did not meet its primary endpoint of reducing cardiovascular mortality and recurrent cardiovascular events. The study demonstrated a favorable safety profile, with a prespecified monotherapy subgroup showing a nominally significant benefit. These results underscore both the progress made with current... More
Celebrating Dr. John Berk’s Retirement After 30+ Years of Excellence
Join us in wishing Dr. John Berk a happy retirement after 30+ years of dedicated service to the Amyloidosis Center! Our multidisciplinary clinical team continues with his legacy of excellent patient care. Thank you, Dr. Berk!
Advanced Practice Provider Position at Amyloidosis Center
The Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center is seeking a full-time advanced practice provider to support its rapidly expanding program. The provider will work with our cardiologists, hematologists, pulmonologist, nephrologists, neurologists, and gastroenterologist to assist with coordination of patient care in the... More
Farewell to Tracy Joshi, DNP
We wish Tracy Joshi, DNP, all the best as she moves on to a new opportunity. Tracy has been an integral member of the Boston University Amyloidosis Center for seven years, and we deeply appreciate her dedication, compassion, and hard work. Her contributions to patient care and to our team... More
STATEMENT ON AMYLOIDOSIS BY ANN D. PEEL
STATEMENT ON AMYLOIDOSIS BY ANN D. PEEL PRIVATE CITIZEN, BETHESDA, MARYLAND SUBCOMMITTEE ON LABOR, HEALTH AND HUMAN SERVICES, EDUCATION AND RELATED AGENCIES COMMITTEE ON APPROPRIATIONS U.S. HOUSE OF REPRESENTATIVES APRIL 10, 2026 DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH. Mr. Chairman, Amyloidosis is a rare and usually fatal disease. There is no known cure for amyloidosis, an abnormal... More
Podcast: Navigating AL Amyloidosis
Expert insights and patient perspectives on AL amyloidosis Tune in to this series for the latest on AL amyloidosis. Host Shaji Kumar (Mayo Clinic, Rochester, Minnesota, USA) talks to fellow specialists and a person with AL amyloidosis about topics ranging from disease impact to multidisciplinary care. Improving Outcomes in AL Amyloidosis
Dr. Sanchorawala Presents Clinical Trial Results at 67th ASH Meeting
Dr Sanchorawala discussed results of clinical trials at the 67th annual American Society of Hematology meeting in Orlando, FL on Dec 7, 2025. Vaishali Sanchorawala | Videos & Research | VJHemOnc
Dr. Shabatun Islam awarded a Junior Research Grant from the Amyloidosis Foundation
We are proud to share that Dr. Shabatun Islam from the Amyloidosis Center has been awarded a Junior Research Grant from the Amyloidosis Foundation to study Muscle Mass, Frailty, and Self-Reported Physical Activity Behaviors in Older Patients with Transthyretin Cardiac Amyloidosis. This award recognizes Dr. Islam’s dedication to advancing amyloidosis... More
From Awareness to Action: Early Diagnosis and Treatment of ATTR (Transthyretin) Amyloidosis: A CME Online Acivity
This one-hour on-demand video learning module features a panel of expert multidisciplinary providers who specialize in the treatment of ATTR (Transthyretin) Amyloidosis. Their discussion includes a didactic presentation supplemented by patient-case reviews and video vignette interviews of an actual patient living with amyloidosis. ATTR Activity Link
BU Amyloidosis Center Celebrates Dr. Omar Siddiqi’s Promotion
Clinical Associate Professor Omar Siddiqi, MD, Medicine/Cardiovascular Medicine, is a clinician-educator who is the program director of the Cardiovascular Medicine Fellowship and co-director of the cardiovascular module for PISCEs. Dr. Siddiqi also is faculty mentor of the Fellows in Training (FIT) Council of the Massachusetts chapter of the American College of Cardiology... More